1-3 of 3
Heather Cameron
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy

Clara Chen, Gerwin A. Huls, Heather Cameron, Beatrice Suero, Alberto Vasconcelos, Lona Gaugler, C.L. Beach
Journal: Blood
Blood (2021) 138 (Supplement 1): 3015.
https://doi.org/10.1182/blood-2021-148049
Published: 2021
Journal Articles

Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)

Clara Chen, Tim Disher, Muhaimen Siddiqui, Ignazia La Torre, Barry Skikne, MD, Beatrice Suero, Heather Cameron, Roya Gavanji, Chris Cameron
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-136625
Published: 2020
Journal Articles

Obinutuzumab and Chlorambucil Versus Chlorambucil Monotherapy for Treatment of Previously Untreated Chronic Lymphocytic Leukemia Where Fludarabine-Based Chemotherapy Is Considered Inappropriate: A Canadian Cost-Utility Analysis

Heather Cameron, PhD, Melissa Thompson, John-Paul Marino, Michael Duong, Ursula Becker, MSc, Christof Wiesner, PhDMPH
Journal: Blood
Blood (2014) 124 (21): 1288.
https://doi.org/10.1182/blood.V124.21.1288.1288
Published: 2014